Celldex Therapeutics, Inc.
CLDX- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- SEC CIK
- 0000744218
No open-market purchases or sales by Celldex Therapeutics, Inc. insiders were filed in the last 90 days; 253 institutions reported holding it in 13F filings for Q2 2026, worth $3.16B in total; no superinvestor holds it.
13F holders, Q4 2023
Institutional positions in Celldex Therapeutics, Inc. as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 164
- +21 vs. Q3 2023
- Shares held
- 61.0M
- +10.5M (+20.7%) vs. Q3 2023
- Total value
- $2.42B
- +$1.03B (+74.0%) vs. Q3 2023
- New holders
- 33
- 60 more added
- Sold out
- 12
- 45 more reduced
1 institution that held it in Q3 2023 haven't filed for Q4 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CLDX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 253 | $3.16B |
| Q1 2026 | 229 | $2.31B |
| Q4 2025 | 187 | $1.99B |
| Q3 2025 | 184 | $1.83B |
| Q2 2025 | 182 | $1.48B |
| Q1 2025 | 171 | $1.34B |
| Q4 2024 | 174 | $1.86B |
| Q3 2024 | 176 | $2.44B |
| Q2 2024 | 183 | $2.58B |
| Q1 2024 | 197 | $2.91B |
| Q4 2023 | 164 | $2.42B |
| Q3 2023 | 144 | $1.39B |
| Q2 2023 | 150 | $1.70B |
| Q1 2023 | 161 | $1.78B |
| Q4 2022 | 168 | $2.17B |
| Q3 2022 | 160 | $1.39B |
| Q2 2022 | 158 | $1.30B |
| Q1 2022 | 169 | $1.69B |
| Q4 2021 | 181 | $1.79B |
| Q3 2021 | 161 | $2.33B |
| Q2 2021 | 132 | $1.19B |
| Q1 2021 | 115 | $709.5M |
Institutions, Q4 2023
Shares, value and share of portfolio for each institution holding Celldex Therapeutics, Inc.; share changes are against Q3 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| TD Asset Management Inc | 52,322 | $2.08M | 0.00% | −12,600−19.4% | Reduced |
| Alliancebernstein L.P. | 54,080 | $2.14M | 0.00% | −39,201−42.0% | Reduced |
| OrbiMed Advisors LLC | 58,800 | $2.33M | 0.05% | +58,800 | New |
| Kennedy Capital Management, Inc. | 62,172 | $2.47M | 0.05% | −25,222−28.9% | Reduced |
| Citigroup Inc | 62,341 | $2.47M | 0.00% | −7,014−10.1% | Reduced |
| Crestline Management, LP | 67,243 | $2.67M | 0.25% | +4,133+6.5% | Added |
| Acuta Capital Partners, LLC | 69,400 | $2.75M | 1.55% | −52,941−43.3% | Reduced |
| JPMorgan Chase & Co | 75,470 | $2.99M | 0.00% | +12,793+20.4% | Added |
| Rhumbline Advisers | 76,022 | $3.02M | 0.00% | −652−0.9% | Reduced |
| Polar Asset Management Partners Inc. | 94,300 | $3.74M | 0.10% | −38,100−28.8% | Reduced |
| Swiss National Bank | 97,000 | $3.85M | 0.00% | +8,700+9.9% | Added |
| Monashee Investment Management LLC | 100,209 | $3.97M | 0.70% | +100,209 | New |
| Mirador Capital Partners LP | 107,910 | $4.28M | 0.91% | +92+0.1% | Added |
| Exome Asset Management LLC | 111,300 | $4.41M | 4.36% | +111,300 | New |
| Nuveen Asset Management, LLC | 121,195 | $4.81M | 0.00% | +915+0.8% | Added |
| Citadel Advisors LLC | 126,328 | $5.01M | 0.01% | +120,403+2,032.1% | Added |
| Jane Street Group, LLC | 128,161 | $5.08M | 0.01% | +68,747+115.7% | Added |
| Schonfeld Strategic Advisors LLC | 130,542 | $5.18M | 0.04% | +130,542 | New |
| BNP Paribas Arbitrage, SA | 136,601 | $5.42M | 0.01% | +44,878+48.9% | Added |
| Laurion Capital Management LP | 138,531 | $5.49M | 0.20% | +138,531 | New |
| AXA S.A. | 142,170 | $5.64M | 0.02% | −3,439−2.4% | Reduced |
| Barclays PLC | 145,894 | $5.79M | 0.00% | +2,431+1.7% | Added |
| Rafferty Asset Management, LLC | 148,009 | $5.87M | 0.02% | −16,781−10.2% | Reduced |
| UBS Group AG | 158,092 | $6.27M | 0.00% | +136,897+645.9% | Added |
| American Century Companies Inc | 161,051 | $6.39M | 0.00% | +191+0.1% | Added |
| Bank of New York Mellon Corp | 169,139 | $6.71M | 0.00% | +4,982+3.0% | Added |
| Walleye Capital LLC | 169,268 | $6.71M | 0.09% | +10,275+6.5% | Added |
| Ensign Peak Advisors, Inc | 179,611 | $7.12M | 0.01% | +87,482+95.0% | Added |
| Bank of America Corp | 217,814 | $8.64M | 0.00% | +5,557+2.6% | Added |
| Dimensional Fund Advisors LP | 230,471 | $9.14M | 0.00% | −110,879−32.5% | Reduced |
| Silverarc Capital Management, LLC | 247,215 | $9.80M | 3.02% | +247,215 | New |
| Baker Bros. Advisors LP | 247,644 | $9.82M | 0.11% | +247,644 | New |
| TSP Capital Management Group, LLC | 251,495 | $9.97M | 3.46% | −200−0.1% | Reduced |
| Invesco Ltd. | 257,563 | $10.2M | 0.00% | +220,428+593.6% | Added |
| Sphera Funds Management Ltd. | 315,644 | $12.5M | 2.32% | +135,644+75.4% | Added |
| Candriam Luxembourg S.C.A. | 317,509 | $12.6M | 0.09% | −5,000−1.6% | Reduced |
| Woodline Partners LP | 387,652 | $15.4M | 0.17% | +280,156+260.6% | Added |
| Affinity Asset Advisors, LLC | 400,000 | $15.9M | 3.16% | +250,000+166.7% | Added |
| Charles Schwab Investment Management Inc | 409,391 | $16.2M | 0.00% | +47,844+13.2% | Added |
| Price T Rowe Associates Inc | 422,293 | $16.7M | 0.00% | −45,762−9.8% | Reduced |
| Goldman Sachs Group Inc | 437,759 | $17.4M | 0.00% | +25,925+6.3% | Added |
| Northern Trust Corp | 444,805 | $17.6M | 0.00% | −29,115−6.1% | Reduced |
| 5AM Venture Management, LLC | 497,270 | $19.7M | 5.23% | +187,000+60.3% | Added |
| Morgan Stanley | 658,365 | $26.1M | 0.00% | +134,665+25.7% | Added |
| Commodore Capital LP | 701,967 | $27.8M | 2.43% | −4,698−0.7% | Reduced |
| Octagon Capital Advisors LP | 707,526 | $28.1M | 4.49% | −52,372−6.9% | Reduced |
| Eversept Partners, LP | 754,107 | $29.9M | 2.93% | +165,964+28.2% | Added |
| Sofinnova Investments, Inc. | 844,008 | $33.5M | 1.88% | +419,749+98.9% | Added |
| Rock Springs Capital Management LP | 969,646 | $38.5M | 0.95% | +469,545+93.9% | Added |
| Redmile Group, LLC | 993,803 | $39.4M | 1.41% | −642,135−39.3% | Reduced |
| Geode Capital Management, LLC | 1,117,994 | $44.3M | 0.00% | +117,569+11.8% | Added |
| Marshall Wace, LLP | 1,280,084 | $50.8M | 0.10% | +741,765+137.8% | Added |
| Pictet Asset Management Holding SA | 2,225,448 | $88.3M | 0.10% | +374,478+20.2% | Added |
| State Street Corp | 2,377,326 | $94.3M | 0.00% | +84,475+3.7% | Added |
| Bellevue Group AG | 2,416,296 | $95.8M | 1.47% | +516,296+27.2% | Added |
| Point72 Asset Management, L.P. | 2,756,122 | $109.3M | 0.33% | +1,413,722+105.3% | Added |
| Kynam Capital Management, LP | 3,005,904 | $119.2M | 13.49% | −194,096−6.1% | Reduced |
| Vanguard Group Inc | 3,046,331 | $120.8M | 0.00% | +427,827+16.3% | Added |
| Polar Capital Holdings Plc | 3,135,871 | $124.4M | 0.86% | +709,115+29.2% | Added |
| RTW Investments, LP | 3,463,201 | $137.4M | 2.15% | 00.0% | Unchanged |
| Eventide Asset Management, LLC | 3,630,013 | $144.0M | 2.35% | +2,030,013+126.9% | Added |
| BlackRock Inc. | 3,675,692 | $145.8M | 0.00% | +423,738+13.0% | Added |
| Wellington Management Group LLP | 6,476,561 | $256.9M | 0.05% | +1,044,728+19.2% | Added |
| FMR LLC | 7,050,409 | $279.6M | 0.02% | −38,711−0.5% | Reduced |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −44,716−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −26,434−100.0% | Sold out |
| HighVista Strategies LLC | 0 | $0 | 0.00% | −17,482−100.0% | Sold out |
| Los Angeles Capital Management LLC | 0 | $0 | 0.00% | −16,082−100.0% | Sold out |
| AlphaCentric Advisors LLC | 0 | $0 | 0.00% | −15,000−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −11,159−100.0% | Sold out |
| Centiva Capital, LP | 0 | $0 | 0.00% | −9,727−100.0% | Sold out |
| Allspring Global Investments Holdings, LLC | 0 | $0 | 0.00% | −1,941−100.0% | Sold out |
| North Star Investment Management Corp. | 0 | $0 | 0.00% | −800−100.0% | Sold out |
| Headlands Technologies LLC | 0 | $0 | 0.00% | −718−100.0% | Sold out |
| Byrne Asset Management LLC | 0 | $0 | 0.00% | −86−100.0% | Sold out |
| Bogart Wealth, LLC | 0 | $0 | 0.00% | −15−100.0% | Sold out |
| International Biotechnology Trust PLC | – | – | – | – | Not filed |